Published in Histopathology on December 01, 1993
The biliary tree--a reservoir of multipotent stem cells. Nat Rev Gastroenterol Hepatol (2012) 1.50
Classification of hepatocellular carcinoma according to hepatocellular and biliary differentiation markers. Clinical and biological implications. Am J Pathol (1996) 1.35
Synaptophysin: A novel marker for human and rat hepatic stellate cells. Am J Pathol (1999) 1.11
Wound healing in the liver with particular reference to stem cells. Philos Trans R Soc Lond B Biol Sci (1998) 1.03
Expressions of chromogranin A and cathepsin D in human primary hepatocellular carcinoma. World J Gastroenterol (2000) 0.91
Recent advances in the morphological and functional heterogeneity of the biliary epithelium. Exp Biol Med (Maywood) (2013) 0.89
Serum chromogranin-A in hepatocellular carcinoma: diagnostic utility and limits. World J Gastroenterol (2005) 0.87
Parathyroid-hormone-related peptides. A new class of multifunctional proteins. Am J Pathol (1997) 0.86
Gastric cancer associated with overexpression of parathyroid hormone-related peptide (PTHrP) and PTH/PTHrP receptor in relation to tumor progression. J Gastroenterol (1997) 0.78
A case of parathyroid hormone-related peptide producing gallbladder carcinoma and establishment of a cell line, PTHrP-GBK. Dig Dis Sci (2002) 0.77
Denosumab is Effective for Controlling Serum Calcium Levels in Patients with Humoral Hypercalcemia of Malignancy Syndrome: A Case Report on Parathyroid Hormone-related Protein-producing Cholangiocarcinoma. Intern Med (2016) 0.75
Endocrine cells in tumour-bearing lungs. Thorax (1996) 0.75
International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol (1999) 9.11
A classification of chronic hepatitis. Lancet (1968) 6.07
Acrylamide gel electrophoresis of HeLa cell nucleolar RNA. Proc Natl Acad Sci U S A (1967) 5.06
Glucose intolerance but normal satiety in mice with a null mutation in the glucagon-like peptide 1 receptor gene. Nat Med (1996) 2.94
Glucagon-like peptide I stimulates insulin gene expression and increases cyclic AMP levels in a rat islet cell line. Proc Natl Acad Sci U S A (1987) 2.79
Minireview: Glucagon-like peptides regulate cell proliferation and apoptosis in the pancreas, gut, and central nervous system. Endocrinology (2004) 2.65
Insulinotropic glucagon-like peptide 1 agonists stimulate expression of homeodomain protein IDX-1 and increase islet size in mouse pancreas. Diabetes (2000) 2.50
Metformin regulates the incretin receptor axis via a pathway dependent on peroxisome proliferator-activated receptor-α in mice. Diabetologia (2010) 2.40
Base composition of ribosomal RNA precursors in the HeLa cell nucleolus: further evidence of non-conservative processing. J Mol Biol (1968) 2.40
Chemical characterization of leptin-activated neurons in the rat brain. J Comp Neurol (2000) 2.21
The mechanism of host cell protein synthesis inhibition by poliovirus. Virology (1966) 2.20
Differential distribution of hepatitis B surface antigen and hepatitis B core antigen in the liver of hepatitis B patients. Gastroenterology (1976) 2.17
The regulation of RNA synthesis and processing in the nucleolus during inhibition of protein synthesis. J Cell Biol (1969) 2.13
Predicting cardiac complications in patients undergoing non-cardiac surgery. J Gen Intern Med (1986) 2.13
Enhanced insulin secretion and improved glucose tolerance in mice lacking CD26. Proc Natl Acad Sci U S A (2000) 1.91
Inactivation of the winged helix transcription factor HNF3alpha affects glucose homeostasis and islet glucagon gene expression in vivo. Genes Dev (1999) 1.86
Secretion of the intestinotropic hormone glucagon-like peptide 2 is differentially regulated by nutrients in humans. Gastroenterology (1999) 1.79
The effect of interleukin-1, interleukin-6 and its interrelationship on the synthesis of serum amyloid A and C-reactive protein in primary cultures of adult human hepatocytes. Biochem Biophys Res Commun (1988) 1.76
Double incretin receptor knockout (DIRKO) mice reveal an essential role for the enteroinsular axis in transducing the glucoregulatory actions of DPP-IV inhibitors. Diabetes (2004) 1.68
Incomplete septal cirrhosis: histopathological aspects. Histopathology (1988) 1.63
Neuroendocrine function and response to stress in mice with complete disruption of glucagon-like peptide-1 receptor signaling. Endocrinology (2000) 1.63
The development of the intrahepatic bile ducts in man: a keratin-immunohistochemical study. Hepatology (1988) 1.59
The glucagon-like peptide 1 receptor is essential for postprandial lipoprotein synthesis and secretion in hamsters and mice. Diabetologia (2009) 1.58
Binding of the major and large HBsAg to human hepatocytes and liver plasma membranes: putative external and internal receptors for infection and secretion of hepatitis B virus. Hepatology (1990) 1.56
Plasmacytoid monocytes (so-called plasmacytoid T cells) in granulomatous lymphadenitis. Hum Pathol (1989) 1.51
Study of the molecular mechanism of decreased liver synthesis of albumin in inflammation. J Clin Invest (1987) 1.49
Hepatitis C infection and membranoproliferative glomerulonephritis. Lancet (1993) 1.47
Plasmacytoid T cells. Immunohistochemical evidence for their monocyte/macrophage origin. Am J Pathol (1988) 1.46
Human and rat hepatic stellate cells express neurotrophins and neurotrophin receptors. Hepatology (2001) 1.46
Replication infidelity during a single cycle of Ty1 retrotransposition. Proc Natl Acad Sci U S A (1996) 1.45
Immunofluorescent detection of hepatitis B antigen in paraffin-embedded liver tissue. J Immunol Methods (1975) 1.44
Intestinal growth-promoting properties of glucagon-like peptide-2 in mice. Am J Physiol (1997) 1.43
Distribution patterns of hepatitis B surface antigen (HBsAg) in the liver of hepatitis patients. J Clin Pathol (1976) 1.41
Immunohistochemical study of adhesion molecules in liver inflammation. Hepatology (1990) 1.40
Effects of aging and a high fat diet on body weight and glucose tolerance in glucagon-like peptide-1 receptor -/- mice. Endocrinology (1998) 1.40
Plasma collected from heparinized blood is not suitable for HCV-RNA detection by conventional RT-PCR assay. J Virol Methods (1993) 1.38
Alpha-cell-specific expression of the glucagon gene is conferred to the glucagon promoter element by the interactions of DNA-binding proteins. Mol Cell Biol (1988) 1.35
Histochemistry of gamma-glutamyl transpeptidase in rat liver during aflatoxin B1-induced carcinogenesis. J Natl Cancer Inst (1975) 1.33
The LIM domain homeobox gene isl-1 is a positive regulator of islet cell-specific proglucagon gene transcription. J Biol Chem (1995) 1.32
Administration of human fibroblast interferon in chronic hepatitis-B infection. Lancet (1976) 1.31
Enteroendocrine localization of GLP-2 receptor expression in humans and rodents. Gastroenterology (2000) 1.31
Divergent tissue-specific and developmental expression of receptors for glucagon and glucagon-like peptide-1 in the mouse. Endocrinology (1994) 1.30
Collagenous colitis: an abnormal collagen table? Two new cases and review of the literature. Am J Gastroenterol (1982) 1.30
Enhanced glucose-dependent insulinotropic polypeptide secretion and insulinotropic action in glucagon-like peptide 1 receptor -/- mice. Diabetes (1998) 1.28
Neuroendocrine features of reactive bile ductules in cholestatic liver disease. Am J Pathol (1990) 1.28
Glucagon-like peptide-1 receptor signalling selectively regulates murine lymphocyte proliferation and maintenance of peripheral regulatory T cells. Diabetologia (2010) 1.28
Regulation of glucagon-like peptide-1 synthesis and secretion in the GLUTag enteroendocrine cell line. Endocrinology (1998) 1.24
In situ distribution of major histocompatibility complex products and viral antigens in chronic hepatitis B virus infection: evidence that HBc-containing hepatocytes may express HLA-DR antigens. Hepatology (1986) 1.24
Characterization and functional role of voltage gated cation conductances in the glucagon-like peptide-1 secreting GLUTag cell line. J Physiol (2004) 1.23
Cytokeratin expression in hepatocellular carcinoma: an immunohistochemical study. Hum Pathol (1988) 1.23
A cytokeratin immunohistochemical study of cholestatic liver disease: evidence that hepatocytes can express 'bile duct-type' cytokeratins. Histopathology (1989) 1.23
Intrahepatic bile ducts under the lens. J Hepatol (1985) 1.22
Prototypic G protein-coupled receptor for the intestinotrophic factor glucagon-like peptide 2. Proc Natl Acad Sci U S A (1999) 1.22
Established cell lines used in cystic fibrosis research. J Cyst Fibros (2004) 1.21
Glucagon and glucagon-like peptide receptors as drug targets. Curr Pharm Des (2006) 1.21
Keratin immunohistochemistry in normal human liver. Cytokeratin pattern of hepatocytes, bile ducts and acinar gradient. Virchows Arch A Pathol Anat Histopathol (1987) 1.21
Hepatitis B virus DNA detected in formalin-fixed liver specimens and its relation to serologic markers and histopathologic features in chronic liver disease. Am J Pathol (1985) 1.20
Hepatic injury associated with the use of nitrofurans: a clinicopathological study of 52 reported cases. Hepatology (1988) 1.20
Intestinal function in mice with small bowel growth induced by glucagon-like peptide-2. Am J Physiol (1997) 1.20
Organ and species specificity of hepatitis B virus (HBV) infection: a review of literature with a special reference to preferential attachment of HBV to human hepatocytes. J Viral Hepat (1997) 1.15
Hepatitis-B surface antigen in tumour tissue and non-tumorous liver in black patients with hepatocellular carcinoma. Br J Cancer (1980) 1.14
Distribution of rat liver albumin mRNA membrane-bound and free in polyribosomes as determined by molecular hybridization. Proc Natl Acad Sci U S A (1977) 1.14
Identification and characterization of a novel sucrose-non-fermenting protein kinase/AMP-activated protein kinase-related protein kinase, SNARK. Biochem J (2001) 1.13
High prevalence of hepatitis G virus infection compared with hepatitis C virus infection in patients undergoing chronic hemodialysis. Am J Kidney Dis (1998) 1.12
Synaptophysin: A novel marker for human and rat hepatic stellate cells. Am J Pathol (1999) 1.11
Activation of proglucagon gene transcription through a novel promoter element by the caudal-related homeodomain protein cdx-2/3. Mol Cell Biol (1996) 1.10
Vascular adhesion molecules in acute and chronic liver inflammation. Hepatology (1992) 1.09
Structure-function of the glucagon receptor family of G protein-coupled receptors: the glucagon, GIP, GLP-1, and GLP-2 receptors. Receptors Channels (2002) 1.09
Glucagon-like peptide-1, but not glucose-dependent insulinotropic peptide, regulates fasting glycemia and nonenteral glucose clearance in mice. Endocrinology (2000) 1.08
Major histocompatibility class II expression on the small intestinal nervous system in Crohn's disease. Gastroenterology (1992) 1.08
Effect of a short term fast on the distribution of cytoplasmic albumin messenger ribonucleic acid in rat liver. Evidence for formation of free albumin messenger ribonucleoprotein particles. J Biol Chem (1978) 1.07
UVB radiation induces p21Cip1/WAF1 and mediates G1 and S phase checkpoints. Oncogene (1996) 1.07
Light chain deposition disease of the liver associated with AL-type amyloidosis and severe cholestasis. J Hepatol (1991) 1.07
Heparan sulfate proteoglycan expression in normal human liver. Hepatology (1995) 1.06
Glucagon gene 5'-flanking sequences direct expression of simian virus 40 large T antigen to the intestine, producing carcinoma of the large bowel in transgenic mice. J Biol Chem (1992) 1.06
Mouse pancreatic beta-cells exhibit preserved glucose competence after disruption of the glucagon-like peptide-1 receptor gene. Diabetes (1998) 1.06
Hepatitis C virus-RNAs in plasma and in peripheral blood mononuclear cells of hemophiliacs with chronic hepatitis C: evidence for viral replication in peripheral blood mononuclear cells. J Med Virol (1994) 1.05
Hepatitis B surface antigen (HBsAg) in the liver of patients with hepatitis; a comparison with serological detection. J Clin Pathol (1976) 1.05
Identification of a high molecular weight presumptive precursor to albumin mRNA in the nucleus of rat liver and hepatoma cell line H4AZC2. J Biol Chem (1978) 1.05
Identification of glucagon-like peptide 1 (GLP-1) actions essential for glucose homeostasis in mice with disruption of GLP-1 receptor signaling. Diabetes (1998) 1.05
Finishing/polishing of composite and compomer restoratives: effectiveness of one-step systems. Oper Dent (2004) 1.05
Integrins as differential cell lineage markers of primary liver tumors. Am J Pathol (1993) 1.05
Immature sinus histiocytosis. Light- and electron-microscopic features, immunologic phenotype, and relationship with marginal zone lymphocytes. Am J Pathol (1985) 1.05
Proglucagon processing in a rat islet cell line resembles phenotype of intestine rather than pancreas. Endocrinology (1986) 1.04
Distribution of the VLA family of integrins in normal and pathological human liver tissue. Gastroenterology (1991) 1.04
Expression of MHC products by normal and abnormal bile duct epithelium. J Hepatol (1986) 1.04
Loose stools during auranofin treatment: clinical study and some pathogenetic possibilities. J Rheumatol (1983) 1.04
Giant nucleoplasmic RNA in the switch-on of compensatory renal growth. Proc Natl Acad Sci U S A (1969) 1.03
Glucagon-like peptide (GLP)-2 action in the murine central nervous system is enhanced by elimination of GLP-1 receptor signaling. J Biol Chem (2001) 1.03
Granulomatous gastritis: a morphological and diagnostic approach. Histopathology (1993) 1.03
Development and use of a rat albumin cDNA clone to evaluate the effect of chronic ethanol administration on hepatic protein synthesis. Hepatology (1983) 1.02
Immunocytochemical localization of parathyroid hormone-like peptide in the rat fetus. Cancer Res (1991) 1.02
Endonexin II, present on human liver plasma membranes, is a specific binding protein of small hepatitis B virus (HBV) envelope protein. Virology (1993) 1.01
Expression of the novel extracellular matrix component tenascin in normal and diseased human liver. An immunohistochemical study. J Hepatol (1990) 1.01
Ketoconazole-associated hepatic injury. A clinicopathological study of 55 cases. J Hepatol (1986) 1.00
Hepatic endoplasmic reticulum storage diseases. Liver (1992) 1.00
Circulating and tissue forms of the intestinal growth factor, glucagon-like peptide-2. Endocrinology (1997) 1.00
alpha-1-Antitrypsin immunoreactivity in islet cells of adult human pancreas. Cell Tissue Res (1977) 1.00
Biological determinants of intestinotrophic properties of GLP-2 in vivo. Am J Physiol (1997) 1.00